Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus;Bypasschirurgie versus perkutane koronare Intervention bei Patienten mit Diabetes mellitus

Herz

Volumn 35, Issue 3, 2010, Pages 182-190

  Dörr, Rolf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Coronary artery bypass surgery; Coronary revascularization; Diabetes mellitus; Drug eluting stents; Percutaneous coronary intervention; Percutaneous transluminal coronary angioplasty

Indexed keywords

PACLITAXEL;

BARE METAL STENT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REPEAT PROCEDURE; RESTENOSIS; REVIEW; SILENT MYOCARDIAL ISCHEMIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 77952864348     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3342-2     Document Type: Review

References (51)

1. P.W. Serruys M.C. Morice A.P. Kappetein SYNTAX Investigators 2009 Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 961 72 10.1056/NEJMoa0804626 1:CAS:528:DC%2BD1MXislOlsLo%3D 19228612
2. R.L. Frye P. August M.M. Brooks BARI 2D Study Group 2009 A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2503 15 10.1056/NEJMoa0805796 1:CAS:528:DC%2BD1MXntVKqtrw%3D 19502645
3. M.E. Pfisterer M.J. Zellweger K.N. Garratt BARI 2D Study Group 2009 Therapies for type 2 diabetes and coronary artery disease N Engl J Med 361 1407 8 10.1056/NEJMc091419 1:CAS:528:DC%2BD1MXht1Cks7bJ 19797290
4. B.R. Chaitman R.M. Hardison D. Adler BARI 2D Study Group 2009 The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction Circulation 120 2529 40 10.1161/CIRCULATIONAHA.109.913111 1:CAS:528:DC%2BD1MXhsFGgtb3M 19920001
5. G. Tarantini A. Ramondo M. Napodano 2009 PCI versus CABG for multivessel coronary disease in diabetics Catheter Cardiovasc Interv 73 50 8 10.1002/ccd.21757 19089938
6. S. Silber C. Herdeg 2008 Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials Herz 33 196 205 10.1007/s00059-008-3121-5 18568314 (Pubitemid 351581157)
7. A.H. Lauruschkat J. Ennker 2008 Diabetes mellitus in coronary bypass surgery: risks and chances. Treatment concepts for a particularly challenging group of patients Herz 33 212 21 10.1007/s00059-008-3114-4 18568316 (Pubitemid 351581152)
8. N. Reiss G. Kleikamp G. Tenderich 2008 Diabetes mellitus and heart failure - incidence and surgical therapy options Herz 33 206 10 10.1007/s00059-008-3116-2 18568315 (Pubitemid 351581154)
9. M.C. Morice P.W. Serruys J.E. Sousa RAVEL Study Group 2002 A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773 80 10.1056/NEJMoa012843 1:CAS:528:DC%2BD38Xkt1Olsbw%3D 12050336 (Pubitemid 34586912)
10. M. Pfisterer H.P. Brunner-La Rocca P.T. Buser BASKET-LATE Investigators 2006 Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2584 91 10.1016/j.jacc.2006.10.026 1:CAS:528:DC%2BD28XhtlaltrrE 17174201 (Pubitemid 44881238)
11. C. Kaiser M. Pfisterer 2007 Increased rate of stent thrombosis with DES Herz 32 296 300 10.1007/s00059-007-3001-4 17607536 (Pubitemid 47047281)
12. G.W. Stone J.W. Moses S.G. Ellis 2007 Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents N Engl J Med 356 998 1008 10.1056/NEJMoa067193 1:CAS:528:DC%2BD2sXisFKmu7o%3D 17296824 (Pubitemid 46376800)
13. C. Stettler S. Wandel S. Allemann 2007 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 937 48 10.1016/S0140-6736(07)61444-5 1:CAS:528:DC%2BD2sXhtVeqsL7E 17869634 (Pubitemid 47393576)
14. C. Stettler S. Allemann M. Egger 2006 Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials Heart 92 650 7 10.1136/hrt.2005.070698 1:CAS:528:DC%2BD28XkvF2jsL8%3D 16251229
15. Bruckenberger E. 21. Herzbericht 2008 mit Transplantationschirurgie. Sektorenöbergreifende Versorgungsanalyse zur Kardiologie und Herzchirurgie in Deutschland sowie vergleichende Daten aus Österreich und der Schweiz. Hannover: Selbstverlag, 2009.
16. A.H. Lauruschkat B. Arnrich A.A. Albert 2008 Diabetes mellitus as a risk factor for pulmonary complications after coronary bypass surgery J Thorac Cardiovasc Surg 135 1047 53 10.1016/j.jtcvs.2007.07.066 18455583 (Pubitemid 351609029)
17. A.H. Lauruschkat A. Albert B. Arnrich 2006 Experiences collected in more than 2,300 diabetics undergoing coronary artery bypass grafting: patients with a specific risk profile Clin Res Cardiol 95 Suppl1 i7 13 10.1007/s00392-006-1110- 3 16598552 (Pubitemid 43155335)
18. A.H. Lauruschkat B. Arnrich A.A. Albert 2005 Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting Circulation 112 2397 402 10.1161/CIRCULATIONAHA.105.534545 16230496 (Pubitemid 41504488)
19. A.H. Lauruschkat J. Ennker 2004 Diabetes mellitus in coronary artery surgery: therapeutic strategies in the light of recent studies Thorac Cardiovasc Surg 52 349 55 10.1055/s-2004-821322 1:STN:280:DC%2BD2crpvFKntg%3D%3D 15573276 (Pubitemid 40006724)
20. G. Kleikamp A. Maleszka N. Reiss 2004 The impact of diabetes mellitus on the results of coronary artery bypass grafting with respect to left ventricular function Herz 29 556 61 10.1007/s00059-004-2616-y 15340743 (Pubitemid 39166113)
21. H. Hausmann R. Hetzer 2004 Surgical revascularization in patients with diabetes mellitus Herz 29 551 5 10.1007/s00059-004-2564-6 15340742 (Pubitemid 39166112)
22. B. Marcheix F. Vanden Eynden P. Demers 2008 Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery Ann Thorac Surg 86 1181 8 10.1016/j.athoracsur.2008.06.063 18805157
23. R.H. Mehta E. Honeycutt L.K. Shaw 2008 Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions Am Heart J 156 728 35 10.1016/j.ahj.2008.05.033 18926154
24. N.E. West P.N. Ruygrok C.M. Disco 2004 Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients Circulation 109 867 73 10.1161/01.CIR.0000116750.63158.94 14757691 (Pubitemid 38252739)
25. E. Van Belle K. Abolmaali C. Bauters 1999 Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients J Am Coll Cardiol 34 476 85 10.1016/S0735-1097(99)00202-8 10440162
26. L. Rydén E. Standl M. Bartnik Task Force on DiabetesCardiovascular Diseases of the European Society of Cardiology 2007 Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary Eur Heart J 28 88 136 10.1093/eurheartj/ehm124 17220161 (Pubitemid 47355991)
27. L. Rydén E. Standl M. Bartnik Task Force on DiabetesCardiovascular Diseases of the European Society of Cardiology 2007 Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text Eur Heart J 9 SupplC C1 74
28. W. Motz R. Dörr 2009 ESC/EASD joint guidelines on diabetes and cardiovascular diseases Herz 34 21 9 19214406
29. M. Bartnik L. Rydén R. Ferrari Euro Heart Survey Investigators 2004 The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart Eur Heart J 25 1880 90 10.1016/j.ehj.2004.07.027 1:CAS:528:DC%2BD2cXptFOgt7k%3D 15522466 (Pubitemid 39452604)
30. M. Bartnik K. Malmberg A. Norhammar 2004 Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction Eur Heart J 25 1990 7 10.1016/j.ehj.2004.09.021 1:CAS:528: DC%2BD2cXpslWnurg%3D 15541834 (Pubitemid 39486017)
31. M. Lenzen L. Ryden J. Ohrvik Euro Heart Survey Investigators 2006 Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart Eur Heart J 27 2969 74 10.1093/eurheartj/ehl363 17090612 (Pubitemid 44950440)
32. M.J. Zellweger 2006 Prognostic significance of silent coronary artery disease in type 2 diabetes Herz 31 240 5 10.1007/s00059-006-2790-1 16770561 (Pubitemid 43892438)
33. D.V. Anand E. Lim A. Lahiri 2006 The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects Eur Heart J 27 905 12 10.1093/eurheartj/ehi441 16087647
34. L.H. Young F.J. Wackers D.A. Chyun DIAD Investigators 2009 Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial JAMA 301 1547 55 10.1001/jama.2009.476 1:CAS:528:DC%2BD1MXksVylu7s%3D 19366774
35. The Bypass Angioplasty Revascularization Investigation 1996 Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 217 25 10.1056/NEJM199607253350401 (Pubitemid 26249569)
36. The Bypass Angioplasty Revascularization Investigation 1997 Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 96 1761 9
37. The BARI Investigators. 2000 Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status J Am Coll Cardiol 35 1122 9 10.1016/S0735-1097(00)00533-7 (Pubitemid 30206884)
38. CABRI Trial Participants. 1995 First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) Lancet 346 1179 84 10.1016/S0140-6736(95)92896-0
39. C.W. Hamm J. Reimers T. Ischinger 1994 A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass surgery Investigation (GABI) N Engl J Med 331 1037 43 10.1056/NEJM199410203311601 1:STN:280: DyaK2czns1yhug%3D%3D 8090162 (Pubitemid 24317695)
40. S.B. King 3rd N.J. Lembo W.S. Weintraub 1994 A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med 331 1044 50 10.1056/NEJM199410203311602 8090163 (Pubitemid 24317696)
41. SoS Investigators. 2002 Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial Lancet 360 965 70 10.1016/S0140-6736(02)11078-6 (Pubitemid 35284106)
42. P.W. Serruys F. Unger J.E. Sousa Arterial Revascularization Therapies Study Group 2001 Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 1117 24 10.1056/NEJM200104123441502 1:STN:280:DC%2BD3M3ivVaqsg%3D%3D 11297702 (Pubitemid 32285232)
43. V.M. Legrand P.W. Serruys F. Unger Arterial Revascularization Therapy Study 2004 Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease Circulation 109 1114 20 10.1161/01.CIR.0000118504.61212.4B 14993134 (Pubitemid 38332615)
44. J. Daemen K.H. Kuck C. Macaya ARTS-II Investigators 2008 Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial J Am Coll Cardiol 52 1957 67 10.1016/j.jacc.2008.09.010 19055986
45. P.W. Serruys Y. Onuma S. Garg ARTS II Investigators 2010 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 1093 101 10.1016/j.jacc.2009.11.049 20171036
46. S. Silber P. Albertsson F.F. Avilés The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology 2005 Guidelines for percutaneous coronary interventions Eur Heart J 26 804 47 10.1093/eurheartj/ehi564 15769784
47. A.P. Banning S. Westaby M.C. Morice 2010 Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 1067 75 10.1016/j.jacc.2009.09.057 1:CAS:528:DC%2BC3cXkvVeitbY%3D 20079596
48. G. Sianos M.A. Morel A.P. Kappetein 2005 The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 219 27 19758907
49. A. Kapur R.J. Hall I.S. Malik 2010 Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 432 40 10.1016/j.jacc.2009.10.014 20117456
50. R. Hachamovitch S.W. Hayes J.D. Friedman 2003 Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2900 7 10.1161/01.CIR.0000072790.23090.41 12771008 (Pubitemid 36736630)
51. H.L. Dauerman 2010 Percutaneous coronary intervention, diabetes mellitus, and death J Am Coll Cardiol 55 1076 9 10.1016/j.jacc.2009.09.056 20079595